Hydroxyzine Hydrochloride
Product Images NDC 53002-3200

2 FDA label images from Rpk Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hydroxyzine Hydrochloride (NDC 53002-3200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image 1

Image 1
Chemical structure diagram of Hydroxyzine Hydrochloride, showing its molecular components including a chlorophenyl group and a piperazine ring, with two hydrochloride (HCl) units associated.*
FDA Label Image

Label Image (Lbl530023200)

Label Image (Lbl530023200)
The image shows a prescription label for Hydroxyzine Hydrochloride 25 mg tablets, with a package containing 20 tablets. The label includes directions to take 1 tablet 3-4 times a day as needed, a barcode, and space for patient information and clinic name. The product is labeled by RPK Pharmaceuticals, Inc. and includes warnings about drowsiness and alcohol use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.